MedTrace Logo

Topical Treatment of Under Eye Dark Circles and Swelling

NCT01172522 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2015-02-19

Study results available
· View outcomes & findings →

Summary

This study examines topical treatment of under eye circles and swelling.

Conditions

Interventions

DRUG

Fexofenadine

Fexofenadine 1%

DRUG

Placebo

Placebo

Sponsors & Collaborators

  • TKL Research, Inc.

    collaborator INDUSTRY

  • The Connecticut Sinus Center, PC

    lead OTHER

Principal Investigators

  • Edward M Lane, MD · The Connecticut Sinus Center, PC

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2010-09-30
Primary Completion
2010-12-31
Completion
2011-01-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Drugs
Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01172522 on ClinicalTrials.gov